Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,640,683
-
Share change
-
+1,699,128
-
Total reported value
-
$228,620,171
-
Put/Call ratio
-
235%
-
Price per share
-
$12.96
-
Number of holders
-
66
-
Value change
-
+$25,329,638
-
Number of buys
-
37
-
Number of sells
-
30
Institutional Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q2 2016
As of 30 Jun 2016,
BELLICUM PHARMACEUTICALS INC - COM (BLCM) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,640,683 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, First Eagle Investment Management, LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, QVT Financial LP, and MORGAN STANLEY.
This page lists
66
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.